人类肺癌的港口空间有组织的干免疫中心与免疫治疗的反应相关
Jonathan H Chen1,2,3,4, Linda T Nieman5,6, Maxwell Spurrell5,7,8
1Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA. jhchen@broadinstitute.org.
Nature immunology
|March 20, 2024
概括
研究人员在瘤中发现了一种新的"干免疫枢纽",其特征是特定的免疫细胞和化学酶. 这个中心与肺癌中PD-1阻断免疫治疗的更好的患者反应有关.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 瘤微环境 瘤微环境
背景情况:
- 免疫细胞在人体瘤中的空间组织对于理解抗瘤免疫是至关重要的,但仍然不太了解.
- 免疫性瘤具有"免疫枢纽",具有吸引T细胞的化学因子和T细胞,可能表明有利的免疫反应.
- 以前的研究还没有完全阐明免疫枢纽的特定亚型及其与免疫治疗结果的直接相关性.
研究的目的:
- 为了研究免疫细胞在人类肺部瘤中的空间组织.
- 确定免疫枢纽的不同亚型及其与PD-1封锁免疫治疗反应的关联.
- 描述一个新发现的"干免疫枢纽"中的细胞组成和相互作用.
主要方法:
- 对人类免疫治疗前肺癌样本的分析.
- 免疫细胞群体的空间概况和瘤内的化学激素表达.
- 免疫组织化学和多重免疫光学用于识别特定的细胞标记物 (例如TCF7,PD-1,CD8,CCR7,LAMP3,CCL19).
主要成果:
- 在肺瘤中确定了"免疫枢纽",与PD-1封锁的积极反应有关.
- 发现了一种"干免疫枢纽"亚型,与PD-1阻塞治疗的良好结果有很强的相关性.
- 标志着干免疫枢纽与三级淋巴体结构不同,富含干状CD8+T细胞,激活的树突细胞以及特定的纤维细胞和化基因.
- 在干免疫枢纽内观察到偏好的细胞与细胞相互作用,包括 CD8+ T 细胞的巨细胞和与 T 细胞的调节性树突细胞.
结论:
- 免疫细胞的空间组织,特别是干免疫枢纽,是预测患者对PD-1阻断免疫疗法的反应的一个重要因素.
- 干免疫枢纽在肺癌中代表了一个独特的,具有预后相关性的免疫微环境.
- 了解这些免疫结构为人类内免疫反应及其对癌症治疗的影响提供了关键的见解.
更多相关视频
11:00Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
17.1K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.7K
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:27Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907